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ABSTRACT 
 
Purpose: The aim of this work was to investigate the locus and extent of vitronectin (Vn) 
deposition on ex vivo contact lenses and to determine the influence of wear modality together 
with surface and bulk characteristics of the lens material.  
Methods: The quantity and location of Vn deposition on the surfaces of contact lens materials 
was investigated using a novel on-lens cell attachment assay technique.  
Results: Vn mapping showed that deposition resulted from lens-corneal interaction rather than 
solely from the tear film. Higher cell counts on the posterior surface of the lenses were 
determined in comparison to the anterior surface. Overall gross Vn deposition was greater for 
high water content-low modulus materials (117±4 average cell count per field) than low water 
content-high modulus materials (88±6 average cell count per field).   
Conclusions: The role of Vn in plasmin regulation and upregulation is widely recognised. The 
findings in this paper suggest that the locus of Vn on the contact lens surface, which is affected 
by material properties such as modulus, is potentially an important factor in the generation of 
plasmin in the posterior tear film. Consequently, the potential for materials to affect Vn 
deposition will influence lens-induced inflammatory processes. 
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1. Introduction 1 
 2 
There is a growing interest in biomarkers related to inflammation and immunoregulation of the 3 
ocular environment in contact lens wear. One interesting candidate biomarker is vitronectin 4 
(Vn), a prominent inflammatory regulatory glycoprotein and adhesion molecule, which has 5 
been detected in tears [1, 2]. Vn is a relatively small glycoprotein of 459 amino acid residues 6 
[3] and is commonly detected in two forms; a single 75 kDa polypeptide chain and a 65 kDa 7 
subunit linked to a 10 kDa fragment by a disulphide bond [4]. This glycoprotein is involved in 8 
many physiological processes, a number of which are summarised in Table 1. Its functions are 9 
dependent on its binding to various matrix and cellular components, which in turns stabilises 10 
or activates a variety of biological macromolecules.  11 
 12 
One of the primary functions of Vn is to regulate the spreading and attachment of a wide variety 13 
and range of cells [32, 33]. Both Vn has an Arg-Gly-Asp (RGD) cell binding sequence that 14 
enables the individual proteins to bind integrins. The integrin family of heterodimeric proteins, 15 
which directly regulates cellular differentiation, proliferation, and migration - can influence 16 
processes such as wound healing, inflammation, and cancer [34]. Vn also inhibits complement 17 
activity [5, 35]. The concentration of Vn in tears has been shown to be dependent on the tear 18 
state; the levels in reflex, open-eye, and closed-eye tear samples have been reported to be 19 
0.08±0.3 µg/ml, 0.75±0.32 µg/ml and 3.7±2.2 µg/ml respectively [1, 2]. In terms of contact 20 
lens wear bandage lenses doped with recombinant human Vn have been shown to be effective 21 
in the enhancement of corneal epithelial wound healing on excised donor human corneas [36, 22 
37]. 23 
 24 
Initially it was suggested that the majority of Vn came from conjunctival blood vessels [2], but 25 
Vn has since been found within the basement membrane of the corneal epithelium, which may 26 
indicate a possible endogenous source [38]. It has also been proposed that the overall elevation 27 
of protein levels during eye closure is due to an increase in vascular permeability in 28 
combination with the accumulation of leakage products resulting from a reduced tear turnover 29 
[1, 39]. The effect of vascular leakage on the ocular surface and the potential consequences of 30 
the altered overnight ocular environment are at present poorly understood. Although the 31 
parallel influx of certain components, including plasmin and complement proteins [40], are 32 
likely to be related, the anti-inflammatory properties of Vn, such as the inhibition of 33 
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complement lysis and plasmin-mediated inflammation, may be extremely important in 34 
controlling or co-controlling the closed eye environment.  35 
 36 
The aim of this work was to investigate the locus and extent of Vn deposition on ex vivo contact 37 
lenses and to determine the influence of wear modality together with surface and bulk 38 
characteristics of the lens material. To detect the adsorption of Vn onto the contact lens surface, 39 
a probe to visualise and trace its presence was required. This was achieved by using fibroblast 40 
cells as a probe, taking advantage of the adhesive nature and the cell binding domain of Vn. 41 
The importance of vitronectin (and fibronectin) in the contraction process in vitro corneal 42 
wound healing studies with fibroblasts (and myofibroblasts) has been demonstrated and 43 
highlights its influence in cell interaction and movement in the ocular environment [41, 42]. 44 
The value of a cell-based assay for the study of Vn in the post-lens ocular environment is 45 
demonstrated. Such studies provide a basis for understanding and potentially modulating the 46 
upregulation of plasmin in the post-lens tear film.  47 
 48 
2. Materials and methods 49 
 50 
2.1. Reagents and immunochemicals 51 
Rabbit IgG (polyclonal); rabbit anti-human fibronectin (polyclonal); human vitronectin; human 52 
fibronectin – all Sigma Aldrich, Gillingham, UK. Rabbit anti-human vitronectin (polyclonal) 53 
(Gibco, BRL). All other reagents were obtained from Sigma Aldrich, Gillingham, UK, unless 54 
otherwise stated. 55 
 56 
2.2. Cell line 57 
 58 
Mouse 3T3 Swiss Albino embryo fibroblasts cells were purchased from European Collection 59 
of Cell Cultures (ECACC; Salisbury, UK) and grown in Dulbecco’s Modified Eagles Medium 60 
– high glucose (DMEM), supplemented with 10% fetal bovine serum (FBS) and 1% 200 mM 61 
L-glutamine solution. Cells were incubated at 37°C in 5% CO2, and maintained for up to 10 62 
passages. 1 ml of resuspended cells was added to 19 ml HBS prior to each assay at a 63 
concentration of 5x104 cell/ml. Cell viability was determined by the standard trypan blue dye 64 
exclusion test.  65 
 66 
2.3. On-lens cell attachment assay 67 
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 68 
All solutions and analytes were pre-heated to 37°C. A magnesium chloride stock solution 69 
(MgCl2, 50 mM), a rabbit IgG solution (300 µg/ml in HBS) and a 1% solution of glutaraldehyde 70 
in HBS were prepared. The cell assay involves the selective inhibition of the adhesion 71 
molecules, using antibody blocking techniques, to validate the significance of Vn on the lens 72 
surface. An anti-Vn antibody control diluted to 1:100 in HBS was incorporated into the assay 73 
to block the action of Vn and used as a comparison against the Vn standard control wells to 74 
assess the adhesion of Vn onto the lens. The use of an IgG antibody, at 300 µg/ml, as a control 75 
was to negate the action of an arbitrary antibody in the system. The lenses, removed from either 76 
doping solution (control lenses and unworn lenses) or saline (worn lenses), were placed 77 
individually into the appropriate test wells of a 24-well plate. Each well was rinsed with 1 ml 78 
HBS (x3). 1 ml HBS was added to the Vn positive control well, 1 ml of the prepared IgG 79 
solution was added to the antibody control well and 100 µl anti-human Vn diluted with 900 µl 80 
HBS was added to the anti-Vn control well. Each 24-well plate was incubated for 60 minutes, 81 
at 37°C and 5% CO2, and gently agitated every 10 minutes.  82 
 83 
After incubation, the solution from each lens was aspirated by means of a pipette, with care 84 
taken not to touch the lens. 1 ml of the cell solution in HBS at a final cell count of 5x104 cells/ml 85 
was added to each well, in addition to 100 µl of MgCl2 stock. The 24-well plate was then 86 
incubated for a further 60 minutes at 37°C and 5% CO2. Following this second incubation 87 
period, the cell solution from each well was removed and each well and lens was rinsed with 1 88 
ml HBS three times. All lenses were moved to a new 24-well plate and rinsed once with 1 ml 89 
HBS. The cells were fixed in 1 ml of 1% glutaraldehyde stock solution ready for counting.  90 
 91 
2.4. Cell counts 92 
 93 
To count the surface-located cells, each ex vivo lens was notionally divided into two areas; the 94 
edge and the centre. The field of vision in which each individual count was taken was defined 95 
by an internal graticule in the eye piece of the microscope. The eye piece graticule measures 1 96 
cm x 1 cm which, when read under a x10 magnification, allowed a field of vision of 1 mm2. 97 
An average of the four counts at the edge and single count in centre zone are presented. 98 
 99 
2.5. In vitro control experiments 100 
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For the on-lens cell attachment assay, lenses (n=3) were doped with Vn to illustrate that it 101 
adsorbs out of solution on to the contact lens surface. The assay relies on the basis that Vn 102 
adheres to contact lens surfaces and that fibroblast cells with integrin receptors for Vn adhere 103 
to the contact lens using Vn as the binding ligand. An initial experiment was performed to 104 
prove that Vn adsorbed out of solution onto the contact lens surface and that it could be detected 105 
using the fibroblast cell assay. Four Group I unworn polyHEMA lenses were doped for 24 106 
hours with a 20 μg/ml solution of Vn. A duplicate set of unworn, non-doped polyHEMA lenses 107 
were assayed as a control. The choice of a Group I set of lenses in this assay was used to take 108 
the assay to the limits. Group I lenses are known to display lower levels of spoilation over 109 
various wear regimes compared to Groups II and IV and thus could be classed as the lowest 110 
threshold for all lenses to be analysed. For in vitro assays, human Vn at various concentrations 111 
diluted in PBS was used as the positive Vn control (Vn positive control). Prior to in vitro doping 112 
assays, the appropriate lenses were incubated in specific μg/ml concentration of Vn per assay 113 
requirements. The on-lens cell attachment assay was then performed. 114 
 115 
2.6. The effect of concentration, lens water content and lens ionicity on Vn adsorption 116 
 117 
To study the effect of concentration polyHEMA contact lenses (n=4) were used in order to 118 
keep the lens type consistent with the initial experiment and to reduce experiment parameter 119 
variability. The four concentrations of Vn used to dope the lenses were: 1 μg/ml, 5 μg/ml, 10 120 
μg/ml and 20 μg/ml. Control non-doped lenses (n=4) were also analysed. No antibody controls 121 
were required. Two separate assays were designed to assess the influence of the lens on the 122 
adsorption of Vn to its surface. Firstly, a water content assay was performed. The lenses used 123 
were all Vistagel non-ionic lenses (n=4) with water contents of 38%, 42%, 60%, and 75%. 124 
HEMA or HEMA/NVP lenses were chosen to evaluate the effect of lens water content on cell 125 
adhesion because the material is available in a range of water contents. Secondly, an ionicity 126 
assay using non-ionic Group II (vasurfilcon A, n=2) versus ionic Group IV (etafilcon A, n=2) 127 
lenses (both are high water content lenses) was performed. All of the lenses were doped with 128 
Vn at a concentration of 10 μg/ml for 24 hours. Only the Vn positive control and antibody 129 
control lenses were tested. 130 
 131 
2.7. Ex vivo contact lenses assays 132 
 133 
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A range of lenses (Table 2) was worn by asymptomatic subjects in either a daily wear modality, 134 
averaging 196 hours over 2 weeks, or an extended wear modality, averaging 168 hours over 1 135 
week, as specified with each assay. Upon removal, lenses were placed in PBS and stored at 136 
4°C. A total of over 100 lenses was assayed in this study. Cell adhesion on the anterior and 137 
posterior surface of Group IV etafilcon A lenses was analysed. Lenses from 8 subjects were 138 
worn on a daily wear basis (n=8) and on an extended wear (n=8) basis. Centre versus edge 139 
analysis was analysed on Group II (vasurfilcon A, n=8) daily wear and Group IV (etafilcon A, 140 
n=8) daily wear lenses. The study was extended to include one conventional hydrogel lens 141 
material (etafilcon A) and three silicone hydrogel lens materials (lotrafilcon A, lotrafilcon B 142 
and balafilcon A) to assess material variation and lens modulus. Each lens type (n=4) was worn 143 
by the same asymptomatic subject on a daily wear basis and stored in saline solution after 144 
removal. ReNu® multipurpose solution (B&L) was used to clean the lenses where necessary. 145 
Work done previously in our laboratories found that levels of adsorbed Vn were only 146 
marginally reduced (<5%) by treatment with this care solution. This was also found to be the 147 
case with ex vivo lenses. The study and its protocol were approved by an Institutional Review 148 
Board in accordance with the tenets of the Declaration of Helsinki.  149 
 150 
2.8. Assessment of the contributory role of fibronectin 151 
 152 
Fn is an important adhesion protein which, in addition to Vn, has been reported in tears [43]. 153 
Both of these cell attachment-promoting proteins are immunologically unrelated and 154 
biochemically different but, due to the fact that their cell adhesive properties are similar, it was 155 
inadvisable to assume that Vn was solely responsible for both adsorption onto the contact lens 156 
and the cell-mediated adhesion. From a doubling dilution range of standards, a concentration 157 
of 12.5 μg/ml of Fn was selected - taking into account the requirement for a satisfactory cell 158 
count and cost effectiveness. This concentration is similar to those levels used for the Vn 159 
doping experiments, and slightly higher than those levels of Fn measured in tears (~ 4 g/ml 160 
[44]) allowing for a marginal increase in tear levels. The designated, control, anti-Vn and anti-161 
Fn, Group IV etafilcon A lenses were doped in 12.5 μg/ml of Fn for 24 hours. For all initial 162 
validation assays, an anti-Fn antibody at 1:100 in HBS, was also used as a direct comparison 163 
against the anti-Vn antibody and Vn standard controls. Again, this was to either eliminate or 164 
accept the role of Fn as a competitive adhesion molecule in contact lens wear and/or to further 165 
validate the dominant adhesion of Vn onto the contact lens.  166 
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 167 
3. Results 168 
 169 
3.1. In vitro method validation 170 
 171 
The average cell counts on doped lenses were greatest for the Vn positive control lenses (59±3) 172 
and for the antibody control lenses (52±3). The lenses blocked with anti-Vn demonstrated 173 
expected low cell counts (4±2) (Fig. 1). A set of non-doped blank lenses (n=3) was also assayed 174 
where an average background level of <5 cells was observed on all lenses; a similar cell count 175 
to the lenses treated with anti-Vn. The comparison of cell counts between the blank lenses and 176 
doped lenses shows a 20-fold increase in the average cell count per field. These results verify 177 
Vn dependant adhesion of cell fibroblasts to lenses and demonstrate the use of a cell-based 178 
assay to detect Vn. Fn demonstrated poor adsorption out of doping solution onto the contact 179 
lens, displaying low cell counts (10±2) in comparison to Vn-mediated adhesion (59±3). Anti-180 
Fn antibodies which were also incorporated into the assay to negate the role of this adhesive 181 
glycoprotein in the attachment of the cells to the contact lens demonstrated no inhibitory 182 
influence. Thus, it could be concluded that Fn is clearly not involved in cell adhesion with these 183 
cell types and therefore does not adversely interfere with this Vn dominated cell-based assay.   184 
 185 
3.2. The effect of Vn doping concentration, lens water content and ionicity on Vn adsorption 186 
 187 
The higher the concentration of Vn in the doping solution the higher the cell counts. Increasing 188 
the Vn concentration from 1 µg/ml to 20 µg/ml gave an increase in the average cell count per 189 
field from 5±0.8 to 37±2 (Fig. 2). All subsequent lenses doped with Vn were doped with 10 190 
µg/ml as this was found to be the optimum concentration. The effect of lens water content on 191 
cell counts showed the higher the water content of the lens, the higher the Vn-mediated cell 192 
adhesion. Average cell count per field for lenses with water contents of 38% and 75% increased 193 
from 42±0.8 to 58±1 respectively (Fig. 3). The results illustrate the fact that water content does 194 
not have a substantial effect on these non-ionic lenses, but there is a progressive increase in 195 
adsorption with water content, with an assumed tendency to reach a plateau of adsorption. Anti-196 
Vn antibody controls were used to validate the cell-Vn adhesion and to negate cell-lens 197 
interactions. Greater cell counts on high water content ionic Group IV lenses (73±6) were 198 
observed in comparison to high water content non-ionic Group II lenses (53±9) (Fig. 4). High 199 
water content ionic lenses were found to adsorb the greatest protein, in contrast to low water 200 
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content non-ionic lenses. This may suggest that the ionicity of the lens is more important than 201 
the water content with regard to Vn adsorption.  202 
 203 
3.3. Vn deposition on anterior and posterior surfaces of ex vivo lenses in daily wear and 204 
extended wear modalities  205 
 206 
Higher cell counts on the posterior surface of the lenses were determined in comparison to the 207 
anterior surface, irrelevant of the modality of wear, as average cell counts per field increased 208 
by 95% from the anterior to the posterior surface in both wear modalities (Fig. 5). All further 209 
test lenses, therefore, analysed the posterior lens surface only. Greater cell counts were also 210 
detected on extended wear lenses than daily wear lenses with an average increase in cell count 211 
of 46% for both the posterior and anterior surfaces of the lenses.  212 
 213 
3.4. Vn deposition on ex vivo daily wear lenses, center versus edge 214 
 215 
It was noted that there was a difference in locus of Vn deposition on the posterior lens surface. 216 
Therefore, a comparison of Vn adsorption at the centre and edge of the lenses was performed. 217 
Greater Vn deposition was observed at the lens edge compared to the centre, irrespective of the 218 
lens material type. Average increases in cell counts from centre to edge (on the posterior lens 219 
surface) of 68% and 65% were observed for Group II lenses and Group IV lenses respectively 220 
(Fig. 6). The results revealed higher cell counts on the Group IV ionic material in comparison 221 
to the Group II non-ionic material, both for the lens centre with an average cell count increase 222 
of 30% and the lens edge with an average increase of 25%.  223 
 224 
3.5. Material variation and the effect of lens modulus 225 
 226 
The highest levels of Vn deposition was determined on the etafilcon A material (117±4), with 227 
lotrafilcon B, balafilcon A and lotrafilcon A showing decreasing cell counts at the lens edge 228 
(115±4, 107±5, 88±6 respectively) (Fig. 7). The relationship between vitronectin-mediated cell 229 
count and lens modulusin terms of water content is summarised in Table 3. The lower the 230 
modulus, the greater the deposition at the lens edge. Lotrafilcon A, a low water content high 231 
modulus material has a lower edge:centre ratio of 1.3:1, whereas etafilcon A, a high water 232 
content low modulus material, has a higher edge:centre ratio of 3.3:1. A comparison of two 233 
similar lenses revealed that lotrafilcon B, with a lower modulus of 1.0 MPa, had a much greater 234 
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edge:centre ratio in comparison to lotrafilcon A, with a higher modulus of 1.5 MPa. Lotrafilcon 235 
B, the softer material, allows more drape of the lens over the cornea, thus lens-tissue interaction 236 
is emphasised at the lens edge. 237 
 238 
4. Discussion 239 
 240 
The adhesive nature of Vn and its role in fibroblast cell attachment and movement was 241 
exploited to demonstrate the interaction of this glycoprotein with contact lens surfaces and the 242 
influence of the contact lens on Vn deposition out of tears and/or the corneal tissue bed was 243 
established. In vitro doping of contact lenses with Vn at varying concentrations showed a direct 244 
correlation between an increase in Vn concentration and its adsorption onto the contact lens. 245 
Although a plateau was not reached within the concentration levels studied, it can be expected 246 
that a limiting plateau would ultimately be achieved after a gradual increase. However, as 247 
previously stated, Vn concentrations in the eye have been reported at 0.75±0.32 µg/ml in the 248 
open eye [1]. It is therefore extremely unlikely for Vn concentrations to exceed the in vitro 249 
experimental limits of 20 µg/ml, in tears. These results demonstrate that cell adhesion is 250 
dependent upon Vn concentration in solution. However, concentration curves cannot be used 251 
to calculate Vn concentration against cell counts as each assay must be treated separately. It 252 
was also observed that the percentage water content of materials directly affected Vn 253 
adsorption; an increase in water content clearly exhibited a rise in the adsorbed levels of Vn. 254 
In addition, the ionicity of the lens also greatly influenced the adsorption of Vn with greater 255 
accumulation of Vn on the ionic (Group IV) versus the non-ionic (Group II) lenses.   256 
 257 
Deposition of Vn was significantly greater on ex vivo lenses in comparison with lenses doped 258 
with Vn in vitro. Centre versus the edge of the lens analysis revealed interesting differences in 259 
Vn levels. There was a marked increase in Vn accumulation at the edge of the lens in contrast 260 
to the centre of the lens. This phenomenon was evident in both the daily wear and extended 261 
wear regimes. The fact that this preferential adsorption was evident for both wear modalities is 262 
very significant. As the name suggests, daily wear lenses are inserted and removed on a daily 263 
basis. The effect of daily handling of the lens, varying insertion and removal parameters and 264 
cleaning would be expected to change the characteristics of the deposition of Vn. However, 265 
this was not the case and the deposition profiles resembled that of the extended wear modality. 266 
The use of the multipurpose solution had little effect on Vn levels. Both wear modalities 267 
10 
 
appeared to create a Vn rich micro-climate at edge of the lens, which may be the site of 268 
localised inflammatory mediation. 269 
 270 
Vn deposition was predominantly found to occur on the posterior surface of the lens in 271 
accordance with those results established in a preliminary study [45] where significantly 272 
greater levels of Vn were observed on the back surface of a worn lens in comparison with the 273 
front surface irrespective of wear modality or lens material properties. The accumulation at the 274 
posterior lens surface may reflect Vn moving out of the corneal tissue bed due to lens-tissue 275 
interactions, as opposed to simply reflecting tear derived Vn. Aggregation of Vn on the 276 
posterior surface is thought to create a particular micro climate, which due to its multifunctional 277 
nature and ability to bind to numerous ligands and proteins, could lead to the initiation of, or 278 
role in, a number of effector systems. A sliding motion of the eyelid over the lens surface will 279 
bring about fricto-mechanical stimulation [46]. This movement might be expected to stimulate 280 
a biochemical response with the potential to generate an upregulation of particular components 281 
or to activate additional pathways in response to the physical trauma of the eyelid-lens 282 
interaction – modest though that might be. Diminished tear flow at the posterior surface of the 283 
lens, in addition to a reduction in the dynamic interaction with the tissue bed, would be expected 284 
to produce a quite different level of response with the potential adsorption of specific 285 
biochemical components from the more ‘closed’ environment. The importance of anterior 286 
versus posterior lens differential in terms of biochemical interactions and physical parameters 287 
cannot be under estimated and its significance has been reviewed elsewhere [47, 48].  288 
 289 
Greater Vn deposition was also detected on extended wear lenses compared with daily wear 290 
lenses. Taking the total wear time and lens-tissue bed contact into consideration, the cell 291 
attachment was always greater for the extended wear lenses than the daily wear lenses. The 292 
cell attachment observed at the in vitro concentrations equivalent to those found in tears are 293 
much lower than those found on posterior surfaces of worn lenses. This may be explained by 294 
the interaction between the ocular tissue and contact lens, with the posterior microclimate 295 
favouring Vn attachment. The investigation was extended to include Group II and Group IV 296 
material types and a comparison of Vn levels for the central and peripheral regions of the lenses 297 
was carried out on the posterior surface of the lenses. Greater Vn deposition on Group II 298 
materials in contrast with Group IV materials demonstrated that cell attachment is markedly 299 
dependent upon material type, highlighting the potential for materials effects in influencing Vn 300 
deposition and the nature of the post-lens microclimate. Again, an evaluation of the centre 301 
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versus the edge of the lens revealed that a greater Vn concentration resulted on the edge. The 302 
locus of Vn deposition is significant as this may influence the locus of plasmin regulation. 303 
Localised plasmin at the edge has the potential to escape into the tear film, whereas plasmin 304 
regulated at the centre of the lens may become ‘trapped’ in that region. 305 
 306 
The edge:centre cell count ratio was clearly material dependent and it appears that the influence 307 
of modulus on cell adhesion overrides any effect of lens water content and ionicity one. The 308 
modulus of a lens describes its resistance to deformation, where modulus is equal to 309 
stress/strain. In general, it was observed that the lower the modulus, the greater the deposition 310 
of Vn at the lens edge and a low water content high modulus material, such as lotrafilcon A, 311 
has a lower edge:centre ratio compared with a high water content low modulus material, such 312 
as etafilcon A, which has a higher edge:centre ratio. Although the morphology of silicone 313 
hydrogel lenses complicates matters further, the lens modulus is a significant if not dominant 314 
factor.  315 
 316 
The emerging patterns are clear - the presence of a contact lens concentrates Vn near the ocular 317 
tissue bed, and thus the preferential adsorption of Vn, particularly towards the edge, on to the 318 
lens surface reveals a Vn rich post-lens micro climate that can influence localised inflammation 319 
and upregulation of plasmin. Vn is involved in the regulation of fibrinolysis, a consequence of 320 
the fact that it binds and stabilises plasminogen activator inhibitor-1 (PAI-1), which thereby 321 
allows PAI-1 to inhibit the action of tissue plasminogen activator (tPA) and the fibrinolysis 322 
process as a whole [20]. If Vn is localised on a surface adjacent to the cellular site, the 323 
somatomedin B homology region of the protein binds to the active site of PAI-1, thereby 324 
generating plasminogen activator and resulting in the upregulation of plasmin [49]. Tear 325 
plasmin activity has been observed in tear fluid of subjects with corneal disorders, for example 326 
an increase in tear plasmin in particular in corneal ulcers has been demonstrated [50], leading 327 
to the implication that elevated plasmin levels are important in the pathogenesis of ocular 328 
infection and dysfunction. The view is that it is an important potential trigger of additional 329 
events leading, in extreme cases, to pathology in an otherwise healthy tissue. Plasmin, for 330 
example, can cleave Fn (an important adhesion molecule involved in corneal re-epithelisation), 331 
which is significant as Fn degradation is associated with impaired wound healing [51, 52].  332 
 333 
Levels of tear plasmin have been shown to increase progressively in the sequence: no lens 334 
control group, daily wear soft lens group, extended wear soft lens group [53], and it has been 335 
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proposed that the proteolytic activity of plasmin may contribute to corneal epithelial 336 
abnormalities associated with lens wear [49, 53]. Vn localised on the lens surface adjacent to 337 
the corneal surface may remove PAI-1 leading to local upregulation of plasmin in the posterior 338 
tear film. If Vn is localised on a (synthetic) surface adjacent to the cellular site (such as a 339 
chronic wound) it removes PAI-1 from the reaction by fixing it, creating an imbalance in favour 340 
of plasminogen activator. This can result in a local upregulation of active plasmin formation, 341 
thereby controlling an important regulatory mechanism in wound repair; an increase in 342 
degradative proteolysis which may then result in a state of non-healing and excessive 343 
inflammation. 344 
 345 
 It remains unclear whether Vn binds to the lens surface to form a monolayer or whether 346 
constant protein binding continues to occur. Is there an initial layer of Vn formed which is 347 
always retained on the surface or is there constant competitive binding through some form of 348 
proteolysis or denaturation? 349 
 350 
5. Conclusions 351 
 352 
The potential for materials to affect Vn deposition will affect the locus of plasmin generation 353 
and thus influence lens-induced inflammatory processes. Clinical implications of this are yet 354 
to be determined, and further studies are required in order to comment on the ideal properties 355 
of a lens when considering the connection between contact lenses and the consequential 356 
inflammatory process. It can be said that an ideal lens is one that minimises protein interaction 357 
at the surface and that allows more exchange of protein at the edge. The unique conformational 358 
flexibility and multidomain structure of Vn which allows it to bind to a large repertoire of 359 
ligands makes its potential interactions with biomaterials all the more intriguing. Its versatile 360 
binding capabilities and receptor functions could, in the future, be used in the characterisation 361 
of structure-function properties and importantly in the design of new biomaterials.  362 
 363 
The significance of this body of research must lie in the area of wound healing and the 364 
compromised anterior eye. Bandage contact lenses (BCLs) are regularly used to protect the 365 
compromised cornea from further ocular insult, to enable the relief of pain and to improve the 366 
ability of the corneal epithelium to heal. However, the use of contact lenses in therapeutics as 367 
bandage lenses is in its infancy. Lens choice appears to be influenced by convenience and 368 
availability rather than specific knowledge of their biochemistry of the healing process. Little 369 
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is known about the interaction of specific materials with corneal conditions and the way in 370 
which materials can promote/inhibit the healing process. The importance of lens choice is 371 
therefore apparent when evaluating the effect of material on the inflammatory process. Ex vivo 372 
lenses worn in the uncompromised eye only were analysed in this study. The study is currently 373 
being expanded to include lenses worn for bandage use in the compromised eye.  374 
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Figure Legends 
Figure 1. Cell counts on Vn doped (20 µg/ml) polyHEMA lenses in vitro. The greatest cell counts were 
found to be on Vn positive control lenses (59±3.3) and similar levels were found as expected on the 
antibody control lenses (52±3). Lenses treated with the anti‐Vn negative control were found to have 
the lowest cell counts (4±2), validating the role of Vn for cell adhesion. 
 
Figure 2. Cell  counts with  varying  concentrations of  vitronectin on polyHEMA  lenses  in  vitro. The 
higher the doping concentration of Vn, the higher the cell counts;  increasing the Vn concentration 
from 1 µg/ml to 20 µg/ml gave an increase in the average cell count per field from 5±0 to 37±1.7. 
 
Figure 3. The relationship between Vn‐mediated cell counts and lens water content. The higher the 
water content of the lens, the higher the Vn‐mediated cell adhesion; the average cell count per field 
for lenses with water contents of 38% and 75% increased from 42±0.8 to 58±0.96 respectively.  
 
Figure 4. The relationship between Vn‐mediated cell counts and lens ionicity. High water content ionic 
Group  IV  lenses had greater cell counts (etafilcon A 73±6) compared with high water content non‐
ionic Group II lenses (vasurfilcon A 53±9).  
 
Figure 5. Comparative vitronectin‐dependent cell counts on daily wear and extended wear etafilcon A 
lenses:  anterior  versus  posterior. Higher  cell  counts were  always  detected  on  the  posterior  lens 
surface  (daily wear 144±15, extended wear 265±26)  than on  the anterior  lens surface  (daily wear 
7±0.3, extended wear 13±1). Greater cell counts overall were also detected on extended wear (198 
hours wear) lenses in comparison to daily wear (168 hours wear) lenses. 
 
Figure 6. Comparative vitronectin‐dependent cell counts on the posterior surface of ex vivo Group II 
(vasurfilcon A) and Group  IV  (etafilcon A) contact  lenses worn on a daily wear basis: centre versus 
edge. Cell counts on the centre and edge areas. Greater cell attachment was observed at the lens edge 
compared to the centre: cell counts increased from centre to edge for Group II and Group IV lenses 
by 68% and 65% respectively. The ionic Group IV material showed greater cell counts over the entire 
lens surface in comparison to the non‐ionic Group II material.  
 
Figure 7. The influence of lens material, worn on a daily wear basis, on vitronectin‐mediated cell count: 
centre  versus  edge.  The  highest  cell  counts  levels were  found  on  the  etafilcon  A material, with 
lotrafilcon B balafilcon A and lotrafilcon A showing decreasing cell counts respectively at the lens edge.  
 
 
 
  
  
 
 
 
Table 1. A summary of the diverse functions of vitronectin. 
 
Process  Description Consequences 
Complement regulation [5-
7] Inhibition of MAC (C5b-9) Protection of bystander cells 
T-cell cytolysis [8, 9] Inhibition of cell lysis by perforin Protection of bystander cells 
Cellular adhesion [10-14] Integrin binding Migration, attachment and aids healing 
Thrombosis [15-17] Binds thrombin-antithrombin III Inhibits thrombin inactivation, regulating blood coagulation 
Fibrinolysis [18-21]  Stabilizes PAI-1 Anti-proteolytic activity 
Inflammation [22] Binds-endorphin Pain suppressor 
Binds structural 
macromolecules [23-26] 
Heparin, collagen, heparin 
sulphate 
For activation or adhesion to 
surfaces. Healing? 
Growth factor interaction 
[27-29] Vn-GF complexes 
Promote wounding healing and 
cell regulation 
Anti-bacterial [30, 31] Cell-bacteria mediated interaction Enhanced intracellular killing of surface bound bacteria 
 
 
Table 3. The relationship between lens modulus, edge:centre ratio and water content. 
 
 
 
Material  Etafilcon A  Lotrafilcon B  Balafilcon A  Lotrafilcon A 
Modulus (MPa)  0.3 1 1.1 1.5 
Edge : Centre Ratio  3.3 : 1  3.0 : 1  2.5 : 1  1.3 : 1 
Water Content (%)  58  33  36  24 
Table 3. The relationship between lens modulus, edge:centre ratio and water content. 
 
Material Etafilcon A Lotrafilcon B Balafilcon A Lotrafilcon A
Modulus (MPa) 0.3 1 1.1 1.5 
Edge : Centre Ratio 3.3 : 1 3.0 : 1 2.5 : 1 1.3 : 1 
Water Content (%) 58 33 36 24 
